LIGAND PHARMACEUTICALS INC
LGND
30 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 2 11:43 PM | John W KozarichDirector | Sale | 467 | $202.23 | $94.4K | 42,253(D) | View → |
| Apr 1, 2026 | Apr 2 10:56 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $201.24 | $1.0M | 41,382(D) | View → |
| Apr 1, 2026 | Apr 1 8:10 PM | KOZARICH JOHN W | Proposed Sale | 467 | $203.50 | $95.0K | — | View → |
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Sale | 2,161 | $200.76 | $433.8K | 30,724(D) | View → |
| Mar 23, 2026 | Mar 25 3:13 PM | Stephen L SabbaDirector | Sale | 1,000 | $207.87 | $207.9K | 32,793(D) | View → |
| Mar 23, 2026 | Mar 23 8:04 PM | STEPHEN L. SABBA | Proposed Sale | 1,000 | $207.87 | $207.9K | — | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Sale | 3,057 | $225.00 | $687.8K | 21,010(D) | View → |
| Mar 11, 2026 | Mar 11 8:42 PM | OCTAVIO ESPINOZA | Proposed Sale | 3,057 | $212.29 | $649.0K | — | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $206.35 | $1.0M | 36,869(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Sale | 13,423 | $205.83 | $2.8M | 21,662(D) | View → |
| Mar 6, 2026 | Mar 6 9:17 PM | JOHN L LAMATTINA | Proposed Sale | 2,161 | $200.76 | $433.8K | — | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Sale | 2,034 | $201.50 | $409.9K | 33,793(D) | View → |
| Mar 2, 2026 | Mar 5 2:04 AM | John W KozarichDirector | Sale | 467 | $200.50 | $93.6K | 42,720(D) | View → |
| Mar 4, 2026 | Mar 4 9:44 PM | ANDREW REARDON | Proposed Sale | 20,000 | $204.24 | $4.1M | — | View → |
| Mar 4, 2026 | Mar 4 9:39 PM | OCTAVIO ESPINOZA | Proposed Sale | 13,423 | $204.24 | $2.7M | — | View → |
| Mar 3, 2026 | Mar 3 9:27 PM | STEPHEN L. SABBA | Proposed Sale | 2,034 | $201.50 | $409.9K | — | View → |
| Feb 2, 2026 | Feb 4 10:18 PM | John W KozarichDirector | Sale | 467 | $195.91 | $91.5K | 43,187(D) | View → |
| Feb 2, 2026 | Feb 2 9:12 PM | KOZARICH JOHN W | Proposed Sale | 467 | $192.18 | $89.7K | — | View → |
| Jan 2, 2026 | Jan 2 9:04 PM | KOZARICH JOHN W | Proposed Sale | 467 | $188.60 | $88.1K | — | View → |
| Dec 12, 2025 | Dec 12 10:22 PM | OCTAVIO ESPINOZA | Proposed Sale | 1,804 | $188.31 | $339.7K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2